AIMS 2025: Emmanuel J Favaloro’s Haemostasis Tour Hits Finale
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, posted on LinkedIn:
”Just completed my final session as the Australian Institute of Medical and Clinical Scientists (AIMS) 2025 Travelling Orator, in Adelaide for the South Australian (SA)/Northern Territory (NT) Branch. A well organised and well attended (pre-)Christmas meeting where I spoke on the topic of “Advances in Haemostasis”. This assignment has been an honour for me.
In total, 6 different venues, with 11 presentations, covering all states and territories in Australia (bar Queensland and the ACT). In total, around 500 attendees, both young and not so young.
Hope to be selected again before I hang up my haemostasis hat for good.”
Stay updated with Hemostasis Today.
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together
-
Nov 29, 2025, 16:38PF4 Antibody Persistence and Long-term Pathogenicity in VITT